Turkey’s Social Security Institution (SGK) will now cover an additional 32 medications, expanding access to treatment for citizens. The announcement was made by Minister of Labor and Social Security, Vedat Işıkhan. This decision aims to broaden the scope of public healthcare provisions within the country. The newly included drugs will be reimbursed through the SGK system, reducing the financial burden on patients. Details regarding the specific medications added to the list have not yet been released. This expansion is part of ongoing efforts to improve healthcare accessibility and affordability for the Turkish population. The move is expected to benefit a significant number of individuals requiring these treatments.